Skip directly to content


Click image to downlad as a JPEG.


Americans for Tax Fairness (2016). “Gilead Sciences Price Gouger, Tax Dodger,” July, 

“What is the minimum cost per person to cure HCV?” Andrew Hill and Saye Khoo, Department of Pharmacology and Therapeutics, Liverpool University, UK; Bryony Simmons, MetaVirology Ltd, London, UK; Nathan Ford, University of Cape Town, South Africa. 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Kuala Lumpur, Malaysia, July 2013,

“Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries,” Andrew Hill, Saye Khoo, Joe Fortunak, Bryony Simmons, and Nathan Ford. Clin Infect Dis, first published online January 6, 2014

“Rapidly falling costs for new hepatitis C direct-acting antivirals (DAAs): Potential for universal access,” Dzintars Gotham, Melissa Barber, Joseph Fortunak, Anton Pozniak, Andrew Hill. 21st IAC Conference, Durban, South Africa, July 18-22, 2016